HuGE Literature Finder
Records 1-11
The rs1008562, rs2234671, and rs3138060 polymorphisms of the CXCR1 gene are associated with breast cancer risk in a Mexican population.
European review for medical and pharmacological sciences 2020 Oct 24 (19): 9990-10002. Gallegos-Arreola M P, Briseño-Zuno C J, Figuera L E, Sánchez-López J Y, Zúñiga-González G M, Puebla-Pérez A M, Gómez-Meda B C, Montoya-Fuentes H, Delgado-Saucedo J |
Genetic Polymorphisms of CXCL8 (-251) Are Associated with the Susceptibility of Helicobacter pylori Infection Increased the Risk of Inflammation and Gastric Cancer in Thai Gastroduodenal Patients.
Iranian journal of allergy, asthma, and immunology 2019 Aug 18 (4): 393-401. Boonyanugomol Wongwarut, Rukseree Kamolchanok, Kongkasame Worrarat, Palittapongarnpim Prasit, Baik Seung-Chul, Manwong Mereer |
Multiple Gene-Environment Interactions on the Angiogenesis Gene-Pathway Impact Rectal Cancer Risk and Survival.
International journal of environmental research and public health 2017 Sep 14 (10): . Sharafeldin Noha, Slattery Martha L, Liu Qi, Franco-Villalobos Conrado, Caan Bette J, Potter John D, Yasui Yuta |
CXCR2 +1208 CT genotype may predict earlier clinical stage at diagnosis in patients with prostate cancer.
Cytokine 2017 Jun 97 193-200. Franz Juliana M, Portela Pâmela, Salim Patricia H, Berger Milton, Fernando Jobim Luiz, Roesler Rafael, Jobim Mariana, Schwartsmann Gilber |
Interleukin genes and associations with colon and rectal cancer risk and overall survival.
International journal of cancer. Journal international du cancer 2013 Feb 132 (4): 905-15. Bondurant Kristina L, Lundgreen Abbie, Herrick Jennifer S, Kadlubar Susan, Wolff Roger K, Slattery Martha |
Pharmacogenetic angiogenesis profiling for first-line Bevacizumab plus oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Sep 17 (17): 5783-92. Gerger Armin, El-Khoueiry Anthony, Zhang Wu, Yang Dongyun, Singh Harpreet, Bohanes Pierre, Ning Yan, Winder Thomas, Labonte Melissa J, Wilson Peter M, Benhaim Leonor, Paez David, El-Khoueiry Rita, Absenger Gudrun, Lenz Heinz-Jos |
Angiogenesis gene polymorphisms and clinical outcome of metastatic colorectal cancer treated with first-line bevacizumab and oxaliplatin-based chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 May 29 (15_suppl): 3592. Gerger A, Zhang W, Yang D, Bohanes P O, Ning Y, Winder T, Labonte M J, Wilson P M, Benhaim L, El-Khoueiry R, Absenger G, El-Khoueiry A B, Iqbal S, Lenz |
Variation in the CXCR1 gene (IL8RA) is not associated with susceptibility to chronic periodontitis.
Journal of negative results in biomedicine 2011 10 (1): 14. Scarel-Caminaga Raquel M, Curtis Karen M C, Renzi Rivelto, Sogumo Patrícia M, Anovazzi Giovana, Viana Aline C, Kim Yeon J, Orrico Silvana R P, Cirelli Joni |
Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness.
BMC cancer 2010 10 (1): 283. Snoussi Kaouther, Mahfoudh Wijden, Bouaouina Noureddine, Fekih Meriem, Khairi Hedi, Helal Ahmed N, Chouchane Lot |
Genetic variation in interleukin 8 and its receptor genes and its influence on the risk and prognosis of prostate cancer among Finnish men in a large cancer prevention trial.
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2006 Jun 15 (3): 249-53. Yang Hannah P, Woodson Karen, Taylor Philip R, Pietinen Pirjo, Albanes Demetrius, Virtamo Jarmo, Tangrea Joseph |
Gene polymorphisms of epidermal growth factor receptor and its downstream effector, interleukin-8, predict oxaliplatin efficacy in patients with advanced colorectal cancer.
Clinical colorectal cancer 2005 Jul 5 (2): 124-31. Zhang Wu, Stoehlmacher Jan, Park David J, Yang Dongyun, Borchard Erin, Gil Ji, Tsao-Wei Denice D, Yun Jim, Gordon Michael, Press Oliver A, Rhodes Katrin, Groshen Susan, Lenz Heinz-Jos |
- Page last reviewed:Oct 1, 2020
- Page last updated:Mar 02, 2021
- Content source: